25% of all the stem cell units released for use by CBR have been collected under their free access initiative
CBR offers access to cord blood banking for families in need through the Newborn Possibilities Program®. For families that have been identified with a qualifying medical condition currently treatable with a cord blood stem cell transplant or a high-risk pregnancy, the Newborn Possibilities Program provides no-cost newborn stem cell processing and five years of storage. The Newborn Possibilities Program is a demonstration of CBR’s commitment to advancing newborn stem cell science and medicine. To date, over 5,000 patients have participated in the program.
Expectant families may be eligible for CBR’s Newborn Possibilities Program if a family member has been diagnosed with certain cancers, such as leukemia, or blood, immune, and metabolic disorders, such as sickle cell anemia, DiGeorge syndrome, and Krabbe disease, which may require a cord blood transplant. Families may also qualify if their newborn is at-risk for a medical condition, such as cerebral palsy, for which cord blood stem cells are currently being investigated as a potential treatment option.
CBR’s certified Genetic Counselors serve as a trusted resource for families interested in learning about how newborn stem cells might be applicable as a potential treatment option. Through family history screening, CBR’s Genetic Counselors can identify families who may benefit from cord blood banking. In addition, the team of certified counselors identifies and assists families eligible to participate in FDA-regulated clinical trials, communicates directly with families in need of a cord blood transplant, and informs clients of their options if their cord blood unit does not adhere to CBR quality standards. To learn more about CBR’s Genetic Counselors, visit http://www.cordblood.com/best-cord-blood-bank/best-stem-cell-bank
About Cord Blood Registry
Cord Blood Registry® (CBR®) is the world’s largest newborn stem cell company. Founded in 1992, CBR is entrusted by parents with storing more than 500,000 cord blood and cord tissue units. CBR is dedicated to advancing the clinical application of newborn stem cells by partnering with leading research institutions to establish FDA-regulated clinical trials, requiring CBR processed cord blood, for conditions that have no cure today. For additional information regarding CBR’s Newborn Possibilities Program, visit http://www.cordblood.com/benefits-cord-blood/family-cord-bloods
SOURCE Cord Blood Registry